Saquinavir mesylate
CAS No. 149845-06-7
Saquinavir mesylate( Ro 31-8959/003 )
Catalog No. M12080 CAS No. 149845-06-7
Apotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSaquinavir mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionApotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays.
-
DescriptionApotent and selective inhibitor of HIV-1 protease with IC50 of 0.5-6 nM in cell assays; binds to the active site of the viral protease and prevents cleavage of viral polyproteins, preventing maturation of the virus; inhibits both HIV-1 and HIV-2 proteases; used to treat or prevent HIV/AIDS.HIV Infection Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 31-8959/003
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number149845-06-7
-
Formula Weight766.9465
-
Molecular FormulaC39H54N6O8S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O
-
Chemical NameButanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, methanesulfonate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martin JA, et al. Biochem Biophys Res Commun. 1991 Apr 15;176(1):180-8.
2. Craig JC, et al. Antiviral Res. 1991 Dec;16(4):295-305.
3. Kr?usslich HG. J Virol. 1992 Jan;66(1):567-72.
molnova catalog
related products
-
SCH 350581
A specific small molecule inhibitor of CCR5, inhibits HIV-1 entry.
-
Ibalizumab
Ibalizumab(TMB-355) is a humanized IgG4 monoclonal antibody that acts as a CD4 receptor inhibitor, blocking the entry of HIV-1 into cells by binding to the CD4 receptor.
-
YYA-021
A small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 9 uM against YTA48P virus with no significant cytotoxicity.
Cart
sales@molnova.com